TauRx’s Alzheimer’s anti-tau drug, HMTM, appears to slow cognitive decline and reduce brain atrophy. There’s just one problem — and it involves blue pee….
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer’s. Following this a bumpy road for another Alzheimer’s drug candidate that could supplant…
The clinical trial failed to show that experimental Alzheimer’s drug crenezumab could prevent cognitive decline. Why the drug failed remains unclear. There were more…
New findings reveal that the way Aduhelm is packaged leads to wasted medication — and as much as $605 million per year of Medicare…
Longeveron’s investigational early-stage Alzheimer’s drug Lomecel-B, made from donated bone marrow, is enrolling participants for a clinical trial. Scientists have faced obstacle after obstacle…
Eyes are on a water retention drug called bumetanide after a recent study showed it was correlated with a lower risk of Alzheimer’s in…
Here’s a primer on all the approved Alzheimer’s drugs designed to treat symptoms or slow disease progression — and a peek ahead at some…